You are here: Industry Insights > antibody

News List

Integral Molecular, AstraZeneca Enter Oncology Antibody Alliance ContractPharma
November 04, 2021
Integral Molecular, a developer of antibodies against membrane proteins, entered an exclusive worldwide antibody license agreement with AstraZeneca to develop therapeutics for multiple cancers.
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 prnasia
September 23, 2021
Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002).
CStone received China NMPA IND approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody, marking further expansion of its Pipeline 2.0 prnasia
September 23, 2021
CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines...
New Test Shows If Your COVID Vaccine is Still Protecting You, Buy Online from Epitome Risk prnewswire
September 23, 2021
Now can now order the only at-home neutralizing antibody test online from Epitome Risk Solutions. The test will tell you if your immune system is still effective in fighting COVID after a vaccination or previous infection.
AbCellera Breaks Ground on Global HQ in Vancouver contractpharma
May 06, 2021
380,000 square feet of facilities envisioned as creative tech hub expected to be completed in 2023 and 2024.
SARS-CoV-2: New findings on the persistence of neutralizing antibodies worldpharmanews
April 19, 2021
It is an open question to what extent protection against reinfection persists after overcoming a SARS-CoV-2 infection. The "Rhineland Study", a population-based study conducted by DZNE in the Bonn area, is now providing new findings in this regard.
Could precipitation reduce the cost of antibody production? europeanpharmaceuticalreview
April 19, 2021
Using a new precipitation method eliminates the need for the costly chromatography process and could make antibody therapies more affordable to produce, according to Andrew Zydney.
Targeting a new antibody supersite key to COVID immunity worldpharmanews
March 22, 2021
Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies.
Antiverse raises £1.4m to bolster AI antibody drug discovery platform pharmatimes
March 17, 2021
Cardiff, Wales-based biotech company Antiverse has raised £1.4m to further advance the development of its AI antibody drug discovery platform.
Lilly, Biolojic to develop antibody therapies for diabetes treatment pharmaceutical-business-review
March 15, 2021
Eli Lilly and Company has signed a research collaboration and license agreement with Biolojic Design to discover and develop therapies for diabetes treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page